BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 22499613)

  • 1. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
    Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ
    J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
    Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
    J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CT.
    Doss M; Zhang JJ; Bélanger MJ; Stubbs JB; Hostetler ED; Alpaugh K; Kolb HC; Yu JQ
    Nucl Med Commun; 2010 Dec; 31(12):1016-24. PubMed ID: 20948452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET-Based Human Dosimetry of the Dimeric αvβ3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
    López-Rodríguez V; Galindo-Sarco C; García-Pérez FO; Ferro-Flores G; Arrieta O; Ávila-Rodríguez MA
    J Nucl Med; 2016 Mar; 57(3):404-9. PubMed ID: 26585063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis.
    Haubner R; Finkenstedt A; Stegmayr A; Rangger C; Decristoforo C; Zoller H; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2005-13. PubMed ID: 27164900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.
    Smolarz K; Krause BJ; Graner FP; Wagner FM; Hultsch C; Bacher-Stier C; Sparks RB; Ramsay S; Fels LM; Dinkelborg LM; Schwaiger M
    J Nucl Med; 2013 Jun; 54(6):861-6. PubMed ID: 23568366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteers.
    Doss M; Kolb HC; Walsh JC; Mocharla VP; Zhu Z; Haka M; Alpaugh RK; Chen DY; Yu JQ
    Mol Imaging Biol; 2014 Oct; 16(5):739-46. PubMed ID: 24696183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
    Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
    Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.
    Mittra ES; Goris ML; Iagaru AH; Kardan A; Burton L; Berganos R; Chang E; Liu S; Shen B; Chin FT; Chen X; Gambhir SS
    Radiology; 2011 Jul; 260(1):182-91. PubMed ID: 21502381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.
    Challapalli A; Sharma R; Hallett WA; Kozlowski K; Carroll L; Brickute D; Twyman F; Al-Nahhas A; Aboagye EO
    J Nucl Med; 2014 Feb; 55(2):256-63. PubMed ID: 24492392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates.
    Tian M; Ogawa K; Wendt R; Mukhopadhyay U; Balatoni J; Fukumitsu N; Uthamanthil R; Borne A; Brammer D; Jackson J; Mawlawi O; Yang B; Alauddin MM; Gelovani JG
    J Nucl Med; 2011 Jun; 52(6):934-41. PubMed ID: 21571803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression.
    Beer AJ; Haubner R; Wolf I; Goebel M; Luderschmidt S; Niemeyer M; Grosu AL; Martinez MJ; Wester HJ; Weber WA; Schwaiger M
    J Nucl Med; 2006 May; 47(5):763-9. PubMed ID: 16644745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.
    Challapalli A; Kenny LM; Hallett WA; Kozlowski K; Tomasi G; Gudi M; Al-Nahhas A; Coombes RC; Aboagye EO
    J Nucl Med; 2013 Sep; 54(9):1551-6. PubMed ID: 23949910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and Radiation Dosimetry for the Tau Tracer
    Hsiao IT; Lin KJ; Huang KL; Huang CC; Chen HS; Wey SP; Yen TC; Okamura N; Hsu JL
    J Nucl Med; 2017 Sep; 58(9):1498-1503. PubMed ID: 28336780
    [No Abstract]   [Full Text] [Related]  

  • 15. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Evaluation of PET-Based Human Biodistribution and Dosimetry of
    Savi A; Incerti E; Fallanca F; Bettinardi V; Rossetti F; Monterisi C; Compierchio A; Negri G; Zannini P; Gianolli L; Picchio M
    J Nucl Med; 2017 Aug; 58(8):1224-1229. PubMed ID: 28209906
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood clearance kinetics, biodistribution, and radiation dosimetry of a kit-formulated integrin αvβ3-selective radiotracer 99mTc-3PRGD 2 in non-human primates.
    Jia B; Liu Z; Zhu Z; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
    Mol Imaging Biol; 2011 Aug; 13(4):730-6. PubMed ID: 20694579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis.
    Sprague DR; Chin FT; Liow JS; Fujita M; Burns HD; Hargreaves R; Stubbs JB; Pike VW; Innis RB; Mozley PD
    J Nucl Med; 2007 Jan; 48(1):100-7. PubMed ID: 17204705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.
    Constantinescu CC; Sevrioukov E; Garcia A; Pan ML; Mukherjee J
    Mol Imaging Biol; 2013 Apr; 15(2):222-9. PubMed ID: 22833323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET.
    Herzog H; Elmenhorst D; Winz O; Bauer A
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1499-506. PubMed ID: 18373090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.